VERSANT HCV Genotype 2.0 Assay (LiPA)
Designed to identify and correctly detect multiple genotypes and subtypes

VERSANT HCV Genotype 2.0 Assay (LiPA)
Neem contact met ons op
In vitro diagnostics, IVD assays - VERSANT HCV Genotype 2.0 Assay (LiPA)
VERSANT HCV Genotype 2.0 Assay (LiPA)

The VERSANT® HCV Genotype 2.0 Assay Line Probe Assay (LiPA) utilizes the trusted reverse-hybridization technology to detect genotypes 1-6 and 15 subtypes including 1a vs.1b and subtypes 6 (c-l) while also taking note of rare patterns that are contained in the updated interpretation chart. This assay is used with the Auto-LiPA 48* and AutoBlot 3000H* automated systems to provide highly accurate identification of HCV genotypes and subtypes for optimal patient therapy.

Share this page:

Related Products, Services & Resources

*Product availability varies from country to country and is subject to local regulatory requirements.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.